Article Details

Biogen : Evaluation of aducanumab efficacy in early Alzheimer's disease at AD/PD

Retrieved on: 2021-03-13 11:26:15

Tags for this article:

Click the tags to see associated articles and topics

Biogen : Evaluation of aducanumab efficacy in early Alzheimer's disease at AD/PD. View article details on hiswai:

Excerpt

Healthcare, Pfizer, and Roche. In the past 2 years, he has received consultancy/speaker fees from AC Immune, Alzpath, Biogen, Cerveau and Roche.

Article found on: www.marketscreener.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up